Mitochondrial activity and oxidative stress functions are influenced by the activation of AhR-induced CYP1A1 overexpression in cardiomyocytes

Zhou,Bing; Wang,Xi; Li,Feng; Wang,Yingting; Yang,Lei; Zhen,Xiaolong; Tan,Wuhong

doi:10.3892/mmr.2017.6580

Mitochondrial activity and oxidative stress functions are influenced by the activation of AhR-induced CYP1A1 overexpression in cardiomyocytes

Authors:
- Bing Zhou
- Xi Wang
- Feng Li
- Yingting Wang
- Lei Yang
- Xiaolong Zhen
- Wuhong Tan
View Affiliations

Affiliations: Key Laboratory of Trace Elements and Endemic Diseases, Xi'an Jiaotong University, Ministry of Health, Xi'an, Shaanxi 710061, P.R. China, Department of Orthopaedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Otolaryngology, Wuqing People's Hospital of Tianjin, Tianjin 301700, P.R. China
Published online on: May 12, 2017 https://doi.org/10.3892/mmr.2017.6580
Pages: 174-180
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There is an endemic cardiomyopathy currently occurring in China, termed, Keshan disease (KD). The authors previously compared mitochondrial‑associated gene expression profiles of peripheral blood mononuclear cells (PBMCs) derived from KD patients and normal controls, using mitochondria‑focused cDNA microarray technology. The results detected an upregulation of the enzyme‑associated CYP1A1 gene, (ratios ≥2.0). The aryl hydrocarbon receptor (AhR) regulates the expression of numerous cytochrome P450 (CYP) genes including members of the CYP1 family; CYP1A1 and CYP1A2. Several previous studies have suggested roles for the aryl hydrocarbon receptor (AhR) and the genes that it regulates. An example involves cytochrome P4501A1 (CYP1A1), in the pathogenesis of heart failure, cardiac hypertrophy and other cardiomyopathies. Mitochondria comprise ~30% of the intracellular volume in mammalian cardiomyocytes, and subtle alterations in mitochondria can markedly influence cardiomyopathies. The present study investigated alterations in the activity and functions of mitochondria following AhR‑induced overexpression of CYP1A1. AC16 cells were treated with the CYP1A1 inducer 2,3,7,8‑tetrachlorodibenzo‑p‑dioxin (TCDD), and cytotoxicity was then evaluated in MTT assays. Reverse transcription‑quantitative polymerase chain reactions, western blot analysis and 7‑ethoxyresorufin O‑deacylase assays were performed to analyze the mRNA and protein levels, and the enzymatic activity of CYP1A1. Mitochondrial activity and mass were analyzed using an inverted fluorescence microscope and a fluorescence microplate reader. Reactive oxygen species (ROS) activity was analyzed using flow cytometry. The results of the current study demonstrated that TCDD gradually increased mRNA and protein levels of AhR and CYP1A1, in addition to the enzymatic activity. Mitochondrial activity and the quality of mitochondrial membranes were also significantly attenuated, and mitochondrial ROS levels were elevated in the TCDD‑induced cardiomyocytes. The results indicate the involvement of the AhR/CYP1A1 signaling pathway in the mechanism of action of TCDD in human cardiomyocytes. The present findings may provide an explanation for myocardial injuries caused by polycyclic aromatic hydrocarbons. The authors conclude that exposure to TCDD results in regulatory alteration to the expression of detoxification genes that ultimately affect the metabolic activation and function of cardiomyocytes.

View Figures

View References

1	Korashy HM and El-Kadi AO: The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. Drug Metab Rev. 38:411–450. 2006. View Article : Google Scholar : PubMed/NCBI
2	Kann S, Huang MY, Estes C, Reichard JF, Sartor MA, Xia Y and Puga A: Arsenite-induced aryl hydrocarbon receptor nuclear translocation results in additive induction of phase I genes and synergistic induction of phase II genes. Mol Pharmacol. 68:336–346. 2005.PubMed/NCBI
3	Nebert DW, Dalton TP, Okey AB and Gonzalez FJ: Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem. 279:23847–23850. 2004. View Article : Google Scholar : PubMed/NCBI
4	Fujii-Kuriyama Y and Mimura J: Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem Biophys Res Commun. 338:311–317. 2005. View Article : Google Scholar : PubMed/NCBI
5	Thum T and Borlak J: Testosterone, cytochrome P450 and cardiac hypertrophy. FASEB J. 16:1537–1549. 2002. View Article : Google Scholar : PubMed/NCBI
6	Granberg AL, Brunström B and Brandt I: Cytochrome P450-dependent binding of 7,12-dimethylbenz[a]anthracene (DMBA) and benzo[a]pyrene (B[a]P) in murine heart, lung and liver endothelial cells. Arch Toxicol. 74:593–601. 2000. View Article : Google Scholar : PubMed/NCBI
7	Zordoky BN and El-Kadi AO: 2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism. Toxicol In Vitro. 24:863–871. 2010. View Article : Google Scholar : PubMed/NCBI
8	Senft AP, Dalton TP, Nebert DW, Genter MB, Puga A, Hutchinson RJ, Kerzee JK, Uno S and Shertzer HG: Mitochondrial reactive oxygen production is dependent on the aromatic hydrocarbon receptor. Free Radic Biol Med. 33:1268–1278. 2002. View Article : Google Scholar : PubMed/NCBI
9	Aboutabl ME and El-Kadi AO: Constitutive expression and inducibility of CYP1A1 in the H9c2 rat cardiomyoblast cells. Toxicol In Vitro. 21:1686–1691. 2007. View Article : Google Scholar : PubMed/NCBI
10	Dong H, Dalton TP, Miller ML, Chen Y, Uno S, Shi Z, Shertzer HG, Bansal S, Avadhani NG and Nebert DW: Knock-in mouse lines expressing either mitochondrial or microsomal CYP1A1: Differing responses to dietary benzo[a]pyrene as proof of principle. Mol Pharmacol. 75:555–567. 2009. View Article : Google Scholar : PubMed/NCBI
11	Schlezinger JJ, White RD and Stegeman JJ: Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3′, 4,4′-tetrachlorobiphenyl: Production of reactive oxygen by vertebrate CYP1As. Mol Pharmacol. 56:588–597. 1999.PubMed/NCBI
12	Schlezinger JJ and Stegeman JJ: Induction and suppression of cytochrome P450 1A by 3,3′,4,4′,5-pentachlorobiphenyl and its relationship to oxidative stress in the marine fish scup (Stenotomus chrysops). Aquat Toxicol. 52:101–115. 2001. View Article : Google Scholar : PubMed/NCBI
13	Claypool SM and Koehler CM: The complexity of cardiolipin in health and disease. Trends Biochem Sci. 37:32–41. 2012. View Article : Google Scholar : PubMed/NCBI
14	Heid SE, Walker MK and Swanson HI: Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol Sci. 61:187–196. 2001. View Article : Google Scholar : PubMed/NCBI
15	De Abrew KN, Thomas-Virnig CL, Rasmussen CA, Bolterstein EA, Schlosser SJ and Allen-Hoffmann BL: TCDD induces dermal accumulation of keratinocyte-derived matrix metalloproteinase-10 in an organotypic model of human skin. Toxicol Appl Pharmacol. 276:171–178. 2014. View Article : Google Scholar : PubMed/NCBI
16	Neri T, Merico V, Fiordaliso F, Salio M, Rebuzzini P, Sacchi L, Bellazzi R, Redi CA, Zuccotti M and Garagna S: The differentiation of cardiomyocytes from mouse embryonic stem cells is altered by dioxin. Toxicol Lett. 202:226–236. 2011. View Article : Google Scholar : PubMed/NCBI
17	Zordoky BN and El-Kadi AO: Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure. Curr Drug Metab. 9:122–128. 2008. View Article : Google Scholar : PubMed/NCBI
18	Gao S, Li H, Cai Y, Ye JT, Liu ZP, Lu J, Huang XY, Feng XJ, Gao H, Chen SR, et al: Mitochondrial binding of α-enolase stabilizes mitochondrial membrane: Its role in doxorubicin-induced cardiomyocyte apoptosis. Arch Biochem Biophys. 542:46–55. 2014. View Article : Google Scholar : PubMed/NCBI
19	Hunter AL, Bai N, Laher I and Granville DJ: Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction. Vascul Pharmacol. 43:213–219. 2005. View Article : Google Scholar : PubMed/NCBI
20	Granville DJ and Gottlieb RA: Having a heart attack? Avoid the ‘HETE’! Am J Physiol Heart Circ Physiol. 291:H485–H487. 2006. View Article : Google Scholar : PubMed/NCBI
21	Nithipatikom K, Gross ER, Endsley MP, Moore JM, Isbell MA, Falck JR, Campbell WB and Gross GJ: Inhibition of cytochrome P450omega-hydroxylase: A novel endogenous cardioprotective pathway. Circ Res. 95:e65–e71. 2004. View Article : Google Scholar : PubMed/NCBI
22	Denison MS, Fisher JM and Whitlock JP Jr: Protein-DNA interactions at recognition sites for the dioxin-Ah receptor complex. J Biol Chem. 264:16478–16482. 1989.PubMed/NCBI
23	Di Lisa F and Bernardi P: Mitochondria and ischemia-reperfusion injury of the heart: Fixing a hole. Cardiovasc Res. 70:191–199. 2006. View Article : Google Scholar : PubMed/NCBI
24	Yue R, Hu H, Yiu KH, Luo T, Zhou Z, Xu L, Zhang S, Li K and Yu Z: Lycopene protects against hypoxia/reoxygenation-induced apoptosis by preventing mitochondrial dysfunction in primary neonatal mouse cardiomyocytes. PLoS One. 7:e507782012. View Article : Google Scholar : PubMed/NCBI
25	Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A and Ruggiero FM: Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: Involvement of reactive oxygen species and cardiolipin. Circ Res. 94:53–59. 2004. View Article : Google Scholar : PubMed/NCBI
26	Papanicolaou KN, Ngoh GA, Dabkowski ER, O'Connell KA, Ribeiro RF Jr, Stanley WC and Walsh K: Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. Am J Physiol Heart Circ Physiol. 302:H167–H179. 2012. View Article : Google Scholar : PubMed/NCBI